09.01.09
Hartmann continued its pattern of growth in the first six months of 2009, reaching sales of €759 million, an increase of 11.9%. With sales growth of 14%, its three medical core segments Wound Management, Incontinence Management and Infection Management continued to drive overall growth. With pleasing organic and inorganic growth in the first six months of 2009, The Hartmann Group improved its operating consolidated net income more than average by 29.5% compared to the previous year. Operating consolidated net income was €29.1 million as of June 30.